Advertisement
Screener

Genmab A/S (GNMSF) Adjustments For Income Tax Expense

2.0 / 5 stars · 16/40 Roast Me

Genmab A/S Adjustments For Income Tax Expense

Genmab A/S (GNMSF) reported Adjustments For Income Tax Expense of -$460.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.

Financial Statements › Expense Statement › Operating Expenses

ifrs-full:AdjustmentsForIncomeTaxExpense · last filed 2026-02-17

DKK

Period endAdjustments For Income Tax Expense 6 monthAdjustments For Income Tax Expense 6 month as first filedAdjustments For Income Tax Expense 12 month
2024-12-31-343.00M DKK
6-K · filed 2025-02-12
2024-06-30-324.00M DKK
6-K · filed 2024-08-08
2023-12-31-1.07B DKK
6-K · filed 2025-02-12
2023-06-30-400.00M DKK
6-K · filed 2024-08-08
2022-12-31-1.58B DKK
6-K · filed 2025-02-12
2022-06-30-455.00M DKK
6-K · filed 2023-08-03
2021-12-31-742.00M DKK
6-K · filed 2024-02-14
2021-06-30-2.00M DKK
6-K · filed 2022-08-10
2020-12-31-1.48B DKK
6-K · filed 2023-02-22
2020-06-30-97.00M DKK
6-K · filed 2021-08-11
2019-12-31-476.00M DKK
6-K · filed 2022-02-16
2019-06-30-140.00M DKK
6-K · filed 2020-08-12
-140.32M DKK
6-K · filed 2019-08-14
2018-12-3146.00M DKK
6-K · filed 2021-02-23
2018-06-30-5.13M DKK
6-K · filed 2019-08-14
2017-12-31-181.00M DKK
20-F · filed 2020-03-30

USD

Period endAdjustments For Income Tax Expense 6 monthAdjustments For Income Tax Expense 12 month
2025-12-31-$460.00M
20-F · filed 2026-02-17
2025-06-30-$315.00M
6-K · filed 2025-08-07
2024-12-31-$50.00M
20-F · filed 2026-02-17
2024-06-30-$47.00M
6-K · filed 2025-08-07
2023-12-31-$155.00M
20-F · filed 2026-02-17